Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Molecular Weight: 360
PPQ-102 is a potent and voltage-independent CFTR inhibitor which completely inhibit CFTR chloride current with IC50 approximately 90 nM
Formula: C18H22F2N4O
resulting in aneuploidy and formation of micronuclei
Smiles: C[C@H]1C=CC=CCCC=CC=CC=CC=CC(CC2O[C@](O)(CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)[C@H](C)[C@@H]1O)CC(O)C2C(O)=O)O[C@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O |t:2
Torcetrapib 02895 Hydrochloride Molecular Weight: 360Torcetrapib, also known as CP 529,414 was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease. Its development was halted in 2006 when phase III studies showed excessive all cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib. Torcetrapib acts (as a CETP inhibitor) by inhibiting cholesterylester transfer protein (CETP), which normally